Soc. Generale Call 12 1U1 21.06.2.../ DE000SV25WG1 /
29.05.2024 18:19:57 | Изменение- | Бид8:24:02 | Предложение8:24:02 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
5.09EUR | - | 4.97 Величина цены спроса: 700 |
5.65 Величина цены предложения: 700 |
1+1 AG INH O.N. | 12.00 - | 21.06.2024 | Call |
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница